| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |